Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia

• Published in: European journal of pharmacology 2022-09, Vol.931, p.175207-175207, Article 175207
• Main Authors: Takase, Saeko, Liao, Jingzhu, Liu, Yue, Tanaka, Rinako, Miyagawa, Yasuhiro, Sawahata, Masahito, Sobue, Akira, Mizoguchi, Hiroyuki, Nagai, Taku, Kaibuchi, Kozo, Ozaki, Norio, Yamada, Kiyofumi
• Format: Article
• Language: English
• Subjects: Behavioral test; Fasudil; MK-801; Schizophrenia
• ISSN: 0014-2999; 1879-0712
• DOI: 10.1016/j.ejphar.2022.175207

Current antipsychotics used to treat schizophrenia have associated problems, including serious side effects and treatment resistance. We recently identified a significant association of schizophrenia with exonic copy number variations in the Rho GTPase activating protein 10 (ARHGAP10) gene using genome-wide analysis. ARHGAP10 encodes a RhoGAP superfamily member that is involved in small GTPase signaling. In mice, Arhgap10 gene variations result in RhoA/Rho-kinase pathway activation. We evaluated the pharmacokinetics of fasudil and hydroxyfasudil using liquid chromatography-tandem mass spectrometry in mice. The antipsychotic effects of fasudil on hyperlocomotion, social interaction deficits, prepulse inhibition deficits, and novel object recognition deficits were also investigated in a MK-801-treated pharmacological mouse schizophrenia model. Fasudil and its major metabolite, hydroxyfasudil, were detected in the brain at concentrations above their respective Ki values for Rho-kinase after intraperitoneal injection of 10 mg kg−1 fasudil. Fasudil improved the hyperlocomotion, social interaction deficits, prepulse inhibition deficits, and novel object recognition deficits in MK-801-treated mice in a dose-dependent manner. Following oral administration of fasudil, brain hydroxyfasudil was detected at concentration above the Ki value for Rho-kinase whilst fasudil was undetectable. MK-801-induced hyperlocomotion was also improved by oral fasudil administration. These results suggest that fasudil has antipsychotic-like effects on the MK-801-treated pharmacological mouse schizophrenia model. There are two isoforms in Rho-kinase, and further investigation is needed to clarify the isoforms involved in the antipsychotic-like effects of fasudil in the MK-801-treated mouse schizophrenia model. [Display omitted] •Fasudil and hydroxyfasudil concentrations reached Ki values for Rho-kinase with fasudil (10 mg kg−1, i.p.).•Fasudil improved MK-801-induced deficits in locomotion, social behavior, prepulse inhibition and novel object recognition.•Fasudil may have antipsychotic-like effects comparable to haloperidol and clozapine in schizophrenia.